Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a trial of S-637880 in neuropathic low back pain
jRCT2031200418Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in neuropathic low back pain (NLBP) comparing S-637880 with Placebo (2 arms). Primary endpoint: Change in maximum daily pain intensity. Started Mar 2021; status: completed.
02
Drugs
S-637880
03
Conditions
neuropathic low back pain (NLBP)
Beyond the preview
Go deeper on jRCT2031200418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200418.